Trial Will Test Mavenclad for Advanced Progressive MS
After some delays due to the COVID-19 pandemic, the Phase 2/3 clinical trial evaluating whether Mavenclad (cladribine) can slow hand and arm function worsening in adults with progressive multiple sclerosis (MS) and very limited walking abilities, has recruited its first patient. The study,Ā ChariotMS (NCT04695080), aims to…